Skip to main content
. 2022 May 18;14:65. doi: 10.1186/s13148-022-01281-z

Table 1.

Main characteristics of the studied children

Mean ± SD
N 47
Sex (M/F) 23/24
Age at rhGH onset (year) 9.8 ± 1.8
Tanner stage (stage 0/stage 1) 36/11
Mean rhGH dose (µg/kg day) 70.8 ± 19
Treatment duration (months) 18.1 ± 7.3
Growth rate before treatment (cm/year) 4.6 ± 1.0
Growth rate during treatment (cm/year) 9.1 ± 1.5
Plasma IGF1 at baseline (ng/ml) 167 ± 80
Mean IGF1during treatment (ng/ml) 402 ± 123
Delta IGF1 under treatment (ng/ml) 235 ± 117